These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 11575176
1. [How are quinolones used in clinical practice? Gyrase antagonists from the viewpoint of the hospital pharmacist]. Schurz JK. Pharm Unserer Zeit; 2001; 30(5):400-5. PubMed ID: 11575176 [No Abstract] [Full Text] [Related]
7. Molecular mechanisms of drug inhibition of DNA gyrase. Lewis RJ, Tsai FT, Wigley DB. Bioessays; 1996 Aug 08; 18(8):661-71. PubMed ID: 8760340 [Abstract] [Full Text] [Related]
8. New generations of quinolones: with particular attention to levofloxacin. Ambrose PG, Owens RC, Quintiliani R, Nightingale CH. Conn Med; 1997 May 08; 61(5):269-72. PubMed ID: 9197076 [No Abstract] [Full Text] [Related]
11. Initial clinical experience with clinafloxacin in the treatment of serious infections. Tack KJ, McGuire NM, Eiseman IA. Drugs; 1995 May 08; 49 Suppl 2():488-91. PubMed ID: 8549411 [No Abstract] [Full Text] [Related]
12. [Quinolones: significance and problems in the clinic and in general practice]. Daschner F, Kappstein I. Internist (Berl); 1988 Mar 08; 29(3):206-12. PubMed ID: 2837440 [No Abstract] [Full Text] [Related]
13. Population pharmacokinetics of marbofloxacin in horses: preliminary analysis. Peyrou M, Doucet MY, Vrins A, Concordet D, Schneider M, Bousquet-Mélou A. J Vet Pharmacol Ther; 2004 Oct 08; 27(5):283-8. PubMed ID: 15500564 [Abstract] [Full Text] [Related]
14. Quinolones in 2005: an update. Van Bambeke F, Michot JM, Van Eldere J, Tulkens PM. Clin Microbiol Infect; 2005 Apr 08; 11(4):256-80. PubMed ID: 15760423 [Abstract] [Full Text] [Related]
15. Injured mitochondria in cells of Euglena gracilis after DNA gyrase inhibitors treatment. Polónyi J, Ebringer L, Krajcovic J, Kapeller K. Z Mikrosk Anat Forsch; 1990 Apr 08; 104(1):61-78. PubMed ID: 2161591 [Abstract] [Full Text] [Related]
16. DNA gyrase as a drug target. Maxwell A. Trends Microbiol; 1997 Mar 08; 5(3):102-9. PubMed ID: 9080608 [Abstract] [Full Text] [Related]
17. Should quinolones be used in the treatment of bacterial infections in neutropenic patients? Piddock LJ, Dalhoff A. J Antimicrob Chemother; 1993 Nov 08; 32(5):771-4. PubMed ID: 8125842 [No Abstract] [Full Text] [Related]
18. [A broad-spectrum antimicrobial preparation--lomefloxacin (Maxaquin): the results of 10 years of its use in the clinics of Russia]. Padeĭskaia EN. Antibiot Khimioter; 2000 Nov 08; 45(1):39-44. PubMed ID: 10690427 [No Abstract] [Full Text] [Related]
19. Clinical results using two new antibiotics--clarithromycin and temafloxacin. Oncology (Williston Park); 1991 Oct 08; 5(10):142, 145-6. PubMed ID: 1664229 [No Abstract] [Full Text] [Related]
20. Update on cross-resistance of fluoroquinolones. Garau J. Int J Clin Pract Suppl; 2000 Dec 08; (115):94-8. PubMed ID: 11219309 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]